You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 66 No. 10, October 2009 TABLE OF CONTENTS
  Archives
  •  Online Features
  Book Reviews
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Headache
 •Pain
 •Drug Therapy
 •Drug Therapy, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Headache and Facial Pain: What Do I Do Now?

by Lawrence C. Newman, MD, and Morris Levin, MD, 172 pp, with illus, $24.95, ISBN 13: 978-0-19-537387-5, Oxford, England: Oxford University Press, 2009.

Ulrike Bingel, MD, Reviewer

Arch Neurol. 2009;66(10):1297.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The majority of patients who present with headaches are successfully managed. At times, however, even experienced clinicians find themselves confounded by complicated patient histories or presentations and wonder "what do I do in this setting?"

In this book, Newman and Levin have tried to predict and help with the management of such difficult cases and explain what they would do in particularly challenging clinical situations. They have described a series of difficult presentations as 33 representative "mini-consultation" scenarios about headache and facial pain.

For instance:

  • How aggressively do you escalate the workup to rule out symptomatic causes of exertional headache in someone with a positive family history of cerebral aneurysm?
  • Do I really need to hold back the therapeutic option of triptans from patients taking selective serotonin reuptake inhibitors? And how compelling is the evidence to avoid triptans in elderly individuals?
  • What do I do for . . . [Full Text of this Article]

AUTHOR INFORMATION



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.